by: Kayla Holt, Central Valley Today is joined by an endocrinologist and a patient with diabetes. They show us how those living with diabetes can keep levels in a healthy range.

This was the stock's third consecutive day of losses.

Some people are facing delays in filling prescriptions for the glucose sensor. Abbott expects to resolve the problem soon.

Abbott Laboratories (ABT) stock saw a decline, ending the day at $114.88 which represents a decrease of $-3.25 or -2.75% from the prior close of $118.13. The stock opened at $117.5 and touched a low ...

Thursday is a big day for Texas A&M University-Fort Worth. But it’s just the first of many big days to come. Gov. Greg Abbott ...

The stakes are extremely high for the nearly 40 million Americans living with diabetes. This condition happens when the body doesn't produce enough insulin or i ...

No-one has ever described Diane Abbott as a riddle or a mystery, let alone an enigma. If ever an MP were frustratingly – or, ...

O'Melveny & Myers is defending Abbott Laboratories in a pending class action against the company and two other co-defendants, ...

Keir Starmer is warning that the NHS must 'reform or die' today after a damning report found billions of pounds in extra ...

William Stanford Davis chats with THR at the 2024 Emmy Awards and dishes on the exciting developments viewers can expect for ...

LAS VEGAS — Republican Texas Gov. Greg Abbott has been in more than a few debates during his decades-long political career. Abbott won three terms as state attorney general before winning ...